Joon Lee
Stock Analyst at Truist Securities
(4.83)
# 96
Out of 5,041 analysts
108
Total ratings
65.09%
Success rate
45.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $85 → $360 | $173.97 | +106.93% | 6 | Oct 17, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $25.93 | +69.69% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $817.32 | +12.32% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $421.39 | +16.28% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $66.40 | +29.52% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $34.42 | +117.90% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $9.21 | +128.01% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $72.52 | +106.84% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $25.60 | +95.31% | 4 | Mar 4, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $129.55 | +54.38% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $67.61 | +77.49% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.21 | +327.55% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.62 | +184.70% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $7.13 | +404.91% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $20.96 | +71.76% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.72 | +115.05% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $11.17 | +52.19% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $54.48 | +65.20% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.07 | +882.80% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $138.53 | +44.37% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.75 | +5.26% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.65 | +287.10% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.12 | +13,107.55% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $35.07 | -3.05% | 1 | Mar 16, 2021 |
Praxis Precision Medicines
Oct 17, 2025
Reiterates: Buy
Price Target: $85 → $360
Current: $173.97
Upside: +106.93%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $25.93
Upside: +69.69%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $817.32
Upside: +12.32%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $421.39
Upside: +16.28%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $66.40
Upside: +29.52%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $34.42
Upside: +117.90%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $9.21
Upside: +128.01%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $72.52
Upside: +106.84%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $25.60
Upside: +95.31%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $129.55
Upside: +54.38%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $67.61
Upside: +77.49%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $4.21
Upside: +327.55%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.62
Upside: +184.70%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $7.13
Upside: +404.91%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $20.96
Upside: +71.76%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $3.72
Upside: +115.05%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $11.17
Upside: +52.19%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $54.48
Upside: +65.20%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.07
Upside: +882.80%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $138.53
Upside: +44.37%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.75
Upside: +5.26%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.65
Upside: +287.10%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.12
Upside: +13,107.55%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $35.07
Upside: -3.05%